Pooled-data analysis identifies pyloric pressures and plasma cholecystokinin concentrations as major determinants of acute energy intake in healthy, lean men

American Journal of Clinical Nutrition

Volumn 92, Issue 1, 2010, Pages 61-68

  Seimon, Radhika V ^a,b   Lange, Kylie ^a,b   Little, Tanya J ^a,b   Brennan, Ixchel M ^a,b   Pilichiewicz, Amelia N ^a,b   Feltrin, Kate L ^a,b   Smeets, Astrid J ^c   Horowitz, Michael ^a,b   Feinle Bisset, Christine ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DATA ANALYSIS; DUODENUM; GASTROINTESTINAL MOTILITY; HORMONE BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MALE; NAUSEA; NORMAL HUMAN; NUTRIENT; PREDICTOR VARIABLE; PYLORUS; STOMACH PRESSURE; APPETITE; BLOOD; BODY MASS; HUNGER; PATHOPHYSIOLOGY; PERCEPTION; PHYSIOLOGY; PREDICTION AND FORECASTING; PRESSURE; REFERENCE VALUE; STOMACH ANTRUM;

ADULT; APPETITE; BODY MASS INDEX; CHOLECYSTOKININ; DUODENUM; ENERGY INTAKE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HUNGER; MALE; NAUSEA; PERCEPTION; PREDICTIVE VALUE OF TESTS; PRESSURE; PYLORIC ANTRUM; PYLORUS; REFERENCE VALUES; YOUNG ADULT;

EID: 77954593115     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.29015     Document Type: Article

References (52)

1. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007;29:6-28.
2. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-46.
3. Feinle C, O'Donovan DG, Doran S, et al. Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol 2003;284: G798-807.
4. Sturm K, Parker B, Feinle-Bisset C, Jones KL, Chapman I, Horowitz M. Energy intake and appetite are related to antral area in healthy young and older subjects. Am J Clin Nutr 2004;80:656-67.
5. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-4.
6. Matzinger D, Gutzwiller JP, Drewe J, et al. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol 1999;277:R1718-24.
7. Brennan IM, Little TJ, Feltrin KL, et al. Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men. Am J Physiol Endocrinol Metab 2008;295:E1487-94.
8. Feltrin KL, Little TJ, Meyer JH, et al. Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 2004;287:R524-33.
9. Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev 2005;6:297-306.
10. Jones KL, Doran SM, Hveem K, et al. Relation between postprandial satiation and antral area in normal subjects. Am J Clin Nutr 1997;66:127-32. (Pubitemid 27278910)
11. Feinle C, Grundy D, Read NW. Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol 1997;273:G721-6.
12. Kissileff HR, Carretta JC, Geliebter A, Pi-Sunyer FX. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 2003;285:R992-8.
13. Pilichiewicz AN, Little TJ, Brennan IM, et al. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2005;290:R668-77.
14. Little TJ, Russo A, Meyer JH, et al. Free fatty acids have more potent effects on gastric emptying, gut hormones, and appetite than triacylglycerides. Gastroenterology 2007;133:1124-31.
15. Beglinger C, Degen L, Matzinger D, D'Amato M, Drewe J. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans. Am J Physiol Regul Integr Comp Physiol 2001;280:R1149-54.
16. Feinle C, Rades T, Otto B, Fried M. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001;120:1100-7.
17. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101:515-20.
18. Tschöp M, Castañeda TR, Joost HG, et al. Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 2004;430:1 p following 165; discussion 2 p following 165. (Published erratum appears in Nature 2004;431:1038.)
19. Brennan IM, Feltrin KL, Horowitz M, et al. Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake and antropyloroduodenal motility in healthy men. Am J Physiol Regul Integr Comp Physiol 2005;288:R1477-85.
20. Long SJ, Sutton JA, Amaee WB, et al. No effect of glucagon-like peptide-1 on short-term satiety and energy intake in man. Br J Nutr 1999;81:273-9.
21. Houghton LA, Read NW, Heddle R, et al. Relationship of the motor activity of the antrum, pylorus, and duodenum to gastric emptying of a solid-liquid mixed meal. Gastroenterology 1988;94:1285-91.
22. Heddle R, Collins PJ, Dent J, et al. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol 1989;4:437-47.
23. Hellström PM, Näslund E. Interactions between gastric emptying and satiety, with special reference to glucagon-like peptide-1. Physiol Behav 2001;74:735-41.
24. Feltrin KL, Patterson M, Ghatei MA, et al. Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. Peptides 2006;27:1638-43.
25. Feltrin KL, Little TJ, Meyer JH, et al. Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men. Am J Clin Nutr 2008;87:1181-7.
26. Pilichiewicz AN, Chaikomin R, Brennan IM, et al. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 2007;293:E743-53.
27. Pilichiewicz AN, Papadopoulos P, Brennan IM, et al. Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2007;293:R2170-8.
28. Little TJ, Feltrin KL, Horowitz M, et al. Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2005;289:R1090-8.
29. Seimon RV, Wooster T, Otto B, et al. The droplet size of intraduodenal fat emulsions influences antropyloroduodenal motility, hormone release, and appetite in healthy males. Am J Clin Nutr 2009;89:1729-36.
30. Brennan IM, Otto B, Feltrin KL, Meyer JH, Horowitz M, Feinle-Bisset C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides 2007;28:607-11.
31. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
32. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005;2:209-17.
33. Parker BA, Sturm K, MacIntosh CG, Feinle C, Horowitz M, Chapman IM. Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects. Eur J Clin Nutr 2004;58:212-8.
34. Samsom M, Roelofs JM, Akkermans LM, van Berge Henegouwen GP, Smout AJ. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 1998;43:491-6.
35. Heddle R, Dent J, Toouli J, Read NW. Topography and me asurement of pyloric pressure waves and tone in humans. Am J Physiol 1988;255:G490-7.
36. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 1-Correlation within subjects. BMJ 1995;310:446.
37. Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods. 2nd ed, illustrated: Thousand Oaks, CA: Sage Publications Inc, 2002.
38. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221.
39. Xu X, Zhu H, Chen JD. Pyloric electrical stimulation reduces food intake by inhibiting gastric motility in dogs. Gastroenterology 2005;128:43-50.
40. Kissileff HR, Pi-Sunyer FX, Thornton J, Smith GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr 1981;34:154-60.
41. Fraser R, Fone D, Horowitz M, Dent J. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans. Gut 1993;34:33-7.
42. Smith GT, Moran TH, Coyle JT, Kuhar MJ, O'Donahue TL, McHugh PR. Anatomic localization of cholecystokinin receptors to the pyloric sphincter. Am J Physiol 1984;264:R127-30.
43. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003;349:941-8.
44. Degen L, Oesch S, Casanova M, et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 2005;129:1430-6.
45. Degen L, Drewe J, Piccoli F, et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol 2007;292:R1391-9.
46. Verdich C, Flint A, Gutzwiller JP, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001;86:4382-9.
47. Gutzwiller JP, Göke B, Drewe J, et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999;44:81-6. (Pubitemid 29143284)
48. Näslund E, Gutniak M, Skogar S, Rössner S, Hellström PM. Glucagon-like peptide-1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 1998;68:525-30.
49. Nagell CF, Pedersen JF, Holst JJ. The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man. Scand J Gastroenterol 2007;42:28-33.
50. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992-5.
51. Jesudason DR, Monteiro MP, McGowan BM, et al. Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr 2007;97:426-9.
52. Nair NS, Brennan IM, Little TJ, et al. Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males. Br J Nutr 2009;101:1094-102.